JP2007230991A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007230991A5 JP2007230991A5 JP2006145134A JP2006145134A JP2007230991A5 JP 2007230991 A5 JP2007230991 A5 JP 2007230991A5 JP 2006145134 A JP2006145134 A JP 2006145134A JP 2006145134 A JP2006145134 A JP 2006145134A JP 2007230991 A5 JP2007230991 A5 JP 2007230991A5
- Authority
- JP
- Japan
- Prior art keywords
- diabetic
- vascular
- disorder
- prophylactic
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 206010061815 Diabetic vascular disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 1
- 206010038683 Respiratory disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Description
該化合物（1）は、糖尿病モデル動物で血管あるいは気管平滑筋の機能異常を改善した事より、糖尿病性血管障害および呼吸障害の予防および／または治療薬として有用である。 The compound (1) is useful as a prophylactic and / or therapeutic drug for diabetic vascular disorder and respiratory disorder because it has improved vascular or tracheal smooth muscle dysfunction in diabetic model animals.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006145134A JP4986505B2 (en) | 2005-05-26 | 2006-05-25 | Preventive and / or therapeutic agent for diabetic vascular disorder and respiratory disorder |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005153990 | 2005-05-26 | ||
| JP2005153990 | 2005-05-26 | ||
| JP2007517718 | 2005-11-24 | ||
| JP2007517718 | 2005-11-24 | ||
| JP2006145134A JP4986505B2 (en) | 2005-05-26 | 2006-05-25 | Preventive and / or therapeutic agent for diabetic vascular disorder and respiratory disorder |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007230991A JP2007230991A (en) | 2007-09-13 |
| JP2007230991A5 true JP2007230991A5 (en) | 2009-04-23 |
| JP4986505B2 JP4986505B2 (en) | 2012-07-25 |
Family
ID=38551939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006145134A Expired - Fee Related JP4986505B2 (en) | 2005-05-26 | 2006-05-25 | Preventive and / or therapeutic agent for diabetic vascular disorder and respiratory disorder |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4986505B2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4861560B2 (en) * | 2001-02-19 | 2012-01-25 | 株式会社明治 | Treatment for diabetic complications |
| CN101065119B (en) * | 2004-11-25 | 2010-08-25 | 明治乳业株式会社 | Ameliorant for renal insufficiency |
-
2006
- 2006-05-25 JP JP2006145134A patent/JP4986505B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2018028I1 (en) | Alogliptin in combination with plaglitazone, each optionally in the form of a pharmaceutically acceptable salt thereof | |
| JP2007520565A5 (en) | ||
| CY2016040I1 (en) | TREATMENT OPTIONS FOR FABRY'S DISEASE | |
| JP2010525055A5 (en) | ||
| JP2007523178A5 (en) | ||
| JP2007536277A5 (en) | ||
| IL178815A0 (en) | The treatment of respiratory disease | |
| HK1171736A1 (en) | Substituted acids for the treatment of respiratory diseases | |
| JP2007501251A5 (en) | ||
| JP2007527914A5 (en) | ||
| JP2011511805A5 (en) | ||
| USD603924S1 (en) | Practice swing club | |
| IL181049A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| JP2006305390A5 (en) | ||
| NO20054180D0 (en) | Treatment of bacterial diseases of the respiratory tract by local administration of fluoroquinolones | |
| DE602005027469D1 (en) | PHARMACEUTICAL COMPOSITION WITH DELAYED TOLTERODINE RELEASE | |
| GB0410399D0 (en) | The treatment of respiratory disease | |
| JP2008526936A5 (en) | ||
| JP2008519810A5 (en) | ||
| JP2007230991A5 (en) | ||
| ZA200800255B (en) | Airway administration of activated protein C in inflammatory conditions affecting the respiratory tract | |
| JP2010526884A5 (en) | ||
| JP2007513894A5 (en) | CHP-gemcitabine combinations and antineoplastic agents, in particular their use as antimetastatic agents | |
| ZA200705080B (en) | Aminocarboxylic acid derivative and medicinal use thereof | |
| JP2007516945A5 (en) |